Richard Moriggl

41PUBLICATIONS
184CO-AUTHORS
Molecular targetsHaematological tumoursEpidemiological modellingInnate immunityCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Oct 15, 2026
Ablation of CDK6 and STAT5B rewires T cell developmental dynamics and prevents ALK+ lymphoma formation.

|Nov 03, 2025
Tyrosine kinase targeting uncovers oncogenic pathway plasticity in Tasmanian devil transmissible cancers.

Anna Schönbichler, Anna Orlova, Carmen Kreindl

|Oct 30, 2025
Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery.

Aleksandr Ianevski, Kristen Nader, Julia Nguyen

|Apr 16, 2025
A direct effect of the hematocrit on blood glucose: Evidence from hypoxia- and erythropoietin-treated mice.

Thomas Scherer, Matthäus Metz, Marianna Beghini

|Apr 15, 2025
Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia.

Annika Dechow, Sanna Timonen, Aleksandr Ianevski

|Jun 28, 2024
Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responses.

Jana von Jan, Sanna Timonen, Till Braun

Pageof 7

Frequent Collaborators

10 joint publications

Heidi Neubauer

6 joint publications

Satu Mustjoki

5 joint publications

Florian Grebien

4 joint publications

Lukas Kenner